SCHEMBL18993263

SCHEMBL18993263

CS(C)(C)C#Cc1cccc(S(=O)(=O)NC2CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
LMNA P02545 2/20 0.53
BRD4 O60885 3/20 0.47
BRD2 P25440 1/20 0.47
BRD3 Q15059 1/20 0.47
KMT2A Q03164 2/20 0.47
PARG Q86W56 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
DPP4 P27487 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
KDM4E B2RXH2 1/20 0.41
RECQL P46063 1/20 0.41
MAPK1 P28482 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16237535 0.82 ALDH1A1 (0.52) ALDH1A1LMNABRD4BRD2BRD3
SCHEMBL16236371 0.80 ALDH1A1 (0.55) ALDH1A1LMNABRD4BRD2BRD3
SCHEMBL16254750 0.79 ALDH1A1 (0.49) ALDH1A1LMNABRD4BRD2BRD3
SCHEMBL13459317 0.76 ALDH1A1 (0.54) ALDH1A1LMNABRD4KMT2APDE4A
SCHEMBL22954414 0.74 MCOLN3 (0.54) ALDH1A1LMNABRD4KMT2ASMN1; SMN2
SCHEMBL11992039 0.74 ALDH1A1 (0.63) ALDH1A1LMNABRD4BRD2BRD3
SCHEMBL1722693 0.74 ALDH1A1 (0.52) ALDH1A1LMNABRD4KMT2APDE4A
SCHEMBL520306 0.72 ALDH1A1 (0.60) ALDH1A1LMNABRD4BRD2BRD3
SCHEMBL29954983 0.72 ALDH1A1 (0.60) ALDH1A1LMNABRD4BRD2BRD3
SCHEMBL2854064 0.71 ALDH1A1 (0.59) ALDH1A1LMNABRD4BRD2BRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682083-B2 Pyrrolo[2,3-D]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2017-06-20 US disclosed